New Monkeypox Testing and Vaccine Codes: July Update (July Special Update (Monkeypox) 2022)

Why This Topic Matters

The update is relevant to professionals who need to recognize newly introduced monkeypox-related CPT codes and understand the surrounding guidance for testing and vaccine services. It helps readers identify which parts of the CPT code set were affected and what general topics the accompanying article addresses.

Article Sections

1. July Special Update (Monkeypox) 2022 page 1

   Introduces the special update and summarizes the new monkeypox-related CPT additions, including testing and vaccine product codes. It also notes the broader CPT publication context and references to external public health guidance.

2. Microbiology

   Covers the laboratory testing portion of the update and places the new testing code within the microbiology area of CPT. The section also discusses the public health context for reporting and tracking testing services.

3. Vaccines, Toxoids

   Covers the vaccine product portion of the update and places the new vaccine codes within the vaccines and toxoids area of CPT. The section also discusses general vaccination context, product background, and related public health references.

4. Clinical Example (87593) / Description of Procedure (87593)

   Provides a representative scenario and associated procedure narrative for the laboratory testing code. It shows the kind of clinical context addressed in the article without substituting for the full guidance.

5. Clinical Example (90611) / Description of Procedure (90611)

   Provides a representative scenario and associated procedure narrative for one of the vaccine product codes. The section illustrates the general type of encounter discussed in the update.

6. Clinical Example (90622) / Description of Procedure (90622)

   Provides a representative scenario and associated procedure narrative for the other vaccine product code. The section illustrates the general type of encounter discussed in the update.